IDR 246.0
(2.5%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1283.12 Billion IDR | 13.51% |
2022 | 1130.37 Billion IDR | 12.94% |
2021 | 1000.85 Billion IDR | -10.06% |
2020 | 1112.83 Billion IDR | 51.37% |
2019 | 735.16 Billion IDR | 3.7% |
2018 | 708.92 Billion IDR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1373.3 Billion IDR | 3.96% |
2024 Q1 | 1320.97 Billion IDR | 2.95% |
2024 Q3 | 1616.83 Billion IDR | 17.73% |
2023 Q2 | 1109.72 Billion IDR | -2.31% |
2023 Q1 | 1136.02 Billion IDR | 0.5% |
2023 FY | 1283.12 Billion IDR | 13.51% |
2023 Q4 | 1283.12 Billion IDR | 5.14% |
2023 Q3 | 1220.43 Billion IDR | 9.98% |
2022 Q2 | 1108.25 Billion IDR | -3.99% |
2022 Q1 | 1154.34 Billion IDR | 15.34% |
2022 FY | 1130.37 Billion IDR | 12.94% |
2022 Q4 | 1130.37 Billion IDR | -4.17% |
2022 Q3 | 1179.59 Billion IDR | 6.44% |
2021 FY | 1000.85 Billion IDR | -10.06% |
2021 Q4 | 1000.85 Billion IDR | 16.08% |
2021 Q3 | 862.19 Billion IDR | -27.23% |
2021 Q2 | 1184.77 Billion IDR | 0.0% |
2021 Q1 | - IDR | -100.0% |
2020 Q4 | 1112.83 Billion IDR | 0.0% |
2020 FY | 1112.83 Billion IDR | 51.37% |
2020 Q1 | - IDR | 0.0% |
2019 FY | 735.16 Billion IDR | 3.7% |
2018 FY | 708.92 Billion IDR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | -23.463% |
PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 64.4% |
PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | -73.148% |
PT Murni Sadar Tbk | 708.74 Billion IDR | -81.042% |
PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 27.485% |
PT Royal Prima Tbk | 49.68 Billion IDR | -2482.501% |
PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -1552.792% |
PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | 7.098% |
PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 56.273% |
PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 65.773% |